Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Forssmann

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Allergy|September 11, 2008
n-Nonanoyl-CCL14 (NNY-CCL14), a novel inhibitor of allergic airway inflammation is a partial agonist of human CCR2S Gupta, G Erdmann, S Schulz-Maronde, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998
HCC-2, a human chemokine: gene structure, expression pattern, and biological activityA Pardigol, U Forssmann, H D Zucht, et al.
The Journal of Experimental Medicine|November 21, 2000
Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV propertiesM Detheux, L Ständker, J Vakili, et al.
The Journal of Experimental Medicine|May 1, 1996
Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxinM Uguccioni, P Loetscher, U Forssmann, et al.
Cell and Tissue Research|November 10, 2001
Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattractionJ R García, F Jaumann, S Schulz, et al.
Investigational New Drugs|June 5, 2014
Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)A Ruzsa, M Sen, M Evans, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Allergy|September 11, 2008
n-Nonanoyl-CCL14 (NNY-CCL14), a novel inhibitor of allergic airway inflammation is a partial agonist of human CCR2S Gupta, G Erdmann, S Schulz-Maronde, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998
HCC-2, a human chemokine: gene structure, expression pattern, and biological activityA Pardigol, U Forssmann, H D Zucht, et al.
The Journal of Experimental Medicine|November 21, 2000
Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV propertiesM Detheux, L Ständker, J Vakili, et al.
The Journal of Experimental Medicine|May 1, 1996
Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxinM Uguccioni, P Loetscher, U Forssmann, et al.
Cell and Tissue Research|November 10, 2001
Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattractionJ R García, F Jaumann, S Schulz, et al.
Investigational New Drugs|June 5, 2014
Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)A Ruzsa, M Sen, M Evans, et al.
Pageof 2